
At Copptech, we firmly believe that the future is based on innovation and strategic collaborations alongside our partners. It is with great enthusiasm that we highlight our alliance with LP Chile, a bold step towards a more innovative tomorrow and connected with our community.
A Commitment to Innovation
Copptech has always been at the forefront of antimicrobial technology, working tirelessly to develop solutions that not only address current challenges but also anticipate future needs. Our mission is about generating a real and positive impact on the lives of people and the communities we serve.
LP Chile: A Bridge to the Community
The collaboration with LP Chile is essential in our mission to strengthen ties with our community. Recognized for their commitment to excellence and quality, LP Chile helps us expand our presence and understand more deeply the needs of our consumers. This alliance not only offers us the possibility to spread our technology and expertise but also to enrich ourselves with the lessons learned in the face of the challenges and opportunities that arise looking towards the future.
Greater Visibility and Approach
Our collaboration with LP Chile has been a catalyst for a notable increase in our visibility in the main media of Chile, significantly improving our market presence. This greater media recognition has solidified our competitive position, providing us with a deeper understanding of the needs of both our current clients and future partners. This extensive exposure has given us a unique opportunity to promote our commitment to innovation and demonstrate the added value of our solutions in people’s daily lives, especially through our advanced antimicrobial technology.
Collaborative Innovation
The collaboration with LP Chile enhances our strengths, merging knowledge and resources to foster innovation in the industry. This partnership allows us to work in a coordinated manner on the development of innovative applications for our antimicrobial technology, optimizing them to meet the demands of various sectors and specific requirements. This synergy not only speeds up the innovation process but also ensures that our solutions are more relevant and accessible to a wide range of users.
Looking to the Future
Looking forward, we are excited about the endless possibilities that this strategic alliance with LP Chile opens for us and our community. We are committed to continuing to work together to explore new frontiers, overcome challenges, and create a future full of significant innovations that benefit everyone.
Conclusion
The strategic alliance between Copptech and LP Chile is a testament to our commitment not only to innovation but also to our community. Together, we are laying the foundations for a future where technology and collaboration come together to create a better and more connected world. With greater visibility in the Chilean media, we are closer than ever to our customers and partners, leading the way towards a future full of innovation.

“The antimicrobial technology that aims to protect the world from microbes”
On November 22nd, in the Work Café Santander program on Radio Infinita, there was a revealing interview between Bárbara Silberberg, co-founder of Copptech, and presenter Soledad Onetto. Throughout this dialogue, key aspects of the company and its innovative technology were explored.
The conversation began with Copptech’s history, from its origins focused on copper formulations to its expansion to other ingredients, demonstrating its continuous evolution and adaptability. This evolution aligns with its venture into the United Kingdom, supported by a strategic partnership with the British government to establish its headquarters there.
During the conversation, Silberberg emphasized Copptech’s commitment to providing protection and well-being to everyone. She remarked: “This is a technology with a powerful benefit that can change the world.” This statement reflected the company’s ambition and conviction in the global impact of its technology.
The essence of Copptech is highlighted by innovation, science, creativity, and flexibility, characteristics ingrained in the DNA of its people, challenging conventional thinking every day. This approach is reflected in the variety of applications and formulations of Copptech across various industries, such as textiles, industrial, plastics, and more. This diversity is made possible through Copptech’s relationships with partners, prioritizing collaboration in the constant pursuit of innovation.
The interview at the Work Café Santander on Radio Infinita not only highlighted Copptech’s cutting-edge technology but also provided a comprehensive view of its history, principles, strategic objectives, and commitment to a positive impact on people. This interview introduced a company committed to innovation and improving the world through its technology.
About Copptech™ Antimicrobial Technology: Copptech™ Antimicrobial Technology is a rapidly growing biotechnology company recognized by Diario Financiero as one of Chile’s 10 most valuable intellectual property brands. Its patented technology uses copper, zinc, and other natural elements to inhibit growth and eliminate up to 99.9% of bacteria and mold, reducing odors, helping food stay fresh longer, and increasing the lifespan of a wide range of materials. Copptech™ Antimicrobial Technology is present in products from Kimba, LP Chile, Arauco, as well as in products from its innovative US-based partner, Purra Performance.
Founded in Santiago, Chile, the company is headquartered in London, United Kingdom, serving clients in Latin America, the United States, and Europe.
You can watch the full interview here

Chile is classified as one of the best countries to invest in Latin America.
Hand in hand with the Chilean firm Copptech, the English executive and investor will participate in Unicorn Kingdom, an initiative that will take place in Chile next week and aims to encourage new national startups to venture into the European market.
by MARÍA JESÚS COLOMA
“Unicorn Kingdom” is a global campaign by the British government aimed at encouraging international technology companies and venture capital funds to do business in the United Kingdom. On November 14, it will land in Chile. Here, local startups will be able to present their projects to a group of British investors, as well as Chilean investors and national companies already established in that European country. One of the participants in the event is Hugh Minnock, investment director of the British fund Foresight Group, who has been able to get to know the Chilean ecosystem after being part of Copptech’s Series B, where they raised US$ 5.5 million in 2021 (see box). Prior to his participation in “Unicorn Kingdom,” Minnock spoke with “El Mercurio” about the potential he sees in the country and the perception of our ecosystem abroad.
– How has your experience been investing in a Chilean company? “Each company we invest in has unique properties and potential. I cannot speak for all Chilean companies, but Copptech certainly has a value proposition that we found attractive, along with their professionalism. It takes commitment along with a community of co-investors who have helped us understand the opportunities available to Copptech both in the United Kingdom and Chile. That said, as with all startups, there are risks, but at Foresight, we offer more than just investment; we partner with our portfolio to share operational knowledge, guidance, and connections, helping the companies we support achieve their business ambitions.
– Do you think Chile is an attractive market for the United Kingdom? “The event ‘Unicorn Kingdom’ and ‘GREAT’ focus on encouraging promising entrepreneurs and innovators to consider the United Kingdom as a place to grow and succeed. The commitment of the United Kingdom government to Chile demonstrates their belief that it is a market that fosters a significant growth spirit both in Latin America and the United Kingdom.”
BÁRBARA SILBERGER OF COPPTECH: “ESPECIALLY USEFUL TO HAVE A FUND WITH GLOBAL EXPERIENCE”
Copptech, a Chilean firm that offers antibacterial and antiviral technology based on copper, currently has a presence in Latin America, the United States, Asia, and recently opened a new office in London and an R&D center in Manchester. In their global perspective, this “allows them to be at the forefront of challenges in all markets and geographies,” says co-founder Bárbara Silberger, who will also participate in “Unicorn Kingdom.” For Silberger, the contribution of investors is key to the company’s growth, but she adds that having the presence of a fund like Foresight also allows them to open new and more doors. “It is especially useful to have a fund with global experience and a firm presence in the United Kingdom, as it can support our efforts as we move beyond Chile and Latin America towards the United States and Europe.” Copptech, founded in Chile in 2014, initially focused on researching and developing its products until 2016 when they had their first connection with the United Kingdom. On that occasion, they conducted clinical trials for the National Health Service (NHS), which revealed that through the developed technology, it could reduce the days by 38%.

Hidden Threats – Termites, the home wreckers
A silent threat in your home, advancing unnoticed. They are so voracious, that they can bring down an entire house, eating its wooden and cellulose structure or foundations.
There are two types of termites:
1) The first type are dark, winged termites. You can see them more often during spring. During summer, you can also see the ones that feed on dry wood, and during autumn, the flying ones are the most prevalent.
2) The second type are white termites. They don’t usually come out, staying inside wooden elements. When they do come out is to regulate humidity and temperature, they usually protect themselves with a type of clay that they secrete.
Termites usually stay inside the wood, but when they do get in contact with humans, they defend themselves. Their bite is not toxic, but it can itch, swell, burn and hurt, especially if you have a predisposition to allergic reactions.
Termite saliva and droppings that come in contact with the skin can cause contact dermatitis and other allergic reactions.
Termites like damp environments, where mold tends to grow, and when termites crawl or chew on wood, they spread mold in their wake. It’s a cycle of pathogen propagation.
Treating a termite infestation yourself, is asking for trouble. Termite pesticides can be harmful to humans on unknowledgeable hands. Always get an expert opinion on how to get rid of termites, and prefer elements that can’t be damaged by them when building your home.

Foresight VCTs invest £5 million in antimicrobial technology developer Copptech
Foresight Group, one of the most relevant Private Equity groups in the UK. has become our new Copptech partner. Their Senior Investment Manager, Hugh Minnock, has recently joined Copptech’s board of directors.
Thanks for joining us in this project with your experience and enthusiasm!
You can learn more about the investment about Fresight Group Investment at the IFA Magazine Article.
We leave you with some words Hugh gave us at his visit to Santiago, Chile.

Look for our Copptech seal!
Return to the places you love.
Our health and safety are directly affected by how we design and maintain our living spaces. When you see our seal, you can feel safe knowing that product or material is protected from the threat that are microbes.
Microbes can cause diseases, material degradation, ruin building materials and cause bad smells. In this precedented times, we need a sense of security to return to our daily activities: to go to the movies, to dinner with family and friends, to the park, or even go to a concert.
Microbes can remain inside building materials for years and above surfaces for many days, (Van Doremalen, 2020).
Our Copptech partners are investing in their client’s protection. Learn more about how to get a Copptech protected product on our website or just send us a message!
Van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., Lloyd-Smith, J. O., de Wit, E., & Munster, V. J. (2020). Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. The New England journal of medicine, 382(16), 1564–1567.

Innovation in Veterinary Surgery and Post-Operative Care
Elizabethan collars are often recommended by veterinarians, especially to prevent dogs and cats from removing their sutures after surgery. They get their name from the lace collars that were fashionable in the time of Queen Elizabeth I. References to their use in veterinary medicine date back to at least 1897. The first Elizabethan pet collars were made of wood, leather or steel; some sources describe the application of buckets with holes in the bottom on dogs to prevent self-harm. There are variations in design, including features to facilitate diameter adjustments or the addition of padding, to ensure that the collars fulfil their function and/or to improve comfort.
Kimba, a Chilean vet company,has partnered with Copptech to create state-of-the-art post-operative clothing for dogs and cats, with Copptech technology, which keep pets’ injured areas clean and protected while they heal – and even heal faster. In a 2020 study, veterinarians at the University of Sydney in Australia conducted a survey of 434 owners whose pets had used the Elizabeth collar in the past year. It concluded that its use causes stress in pets, reduces, among other things, their field of vision and affects their freedom of movement (Shenoda, 2020).
Kimba, together with Copptech were the pioneers in using technology and progress to improve this ancient invention, so that pets could withstand and heal better – and faster,. The creation is called Body Kimba, that can be used in all types of animals and is now considered a the best veterinary measure in Chileans vet-clinics.
Adolfo Momares, the mind behind Kimba, says “The first thing we did was to determine the inconvenience of the Elizabethan collar and the challenges it poses for those of us who care for our pets. That is why we developed a body, which covers, protects and heals these tissues faster. Customised products based on the needs observed in dogs and cats”.
The Kimba Body with Copptech technology, provides an antifungal, antimicrobial effect, permanent protection against infections and a visible improvement in wound healing. “With this clothing, the stress on pets is reduced after treatment or surgery. Now, thanks to the post-operative onesie, you can keep the injured areas clean and protected without having to endure the irritating device on the neck known as the “cone of shame”. Explains Veterinarian, Marcelo Jofré.
Innovation and tecnhnology to improve health and wellbeing! Also protecting our pets. Learn more in our Link https://www.copptech.com/cstaging/pets/
Shenoda, Y., (2020). “The Cone of Shame”: Welfare Implications of Elizabethan Collar Use on Dogs and Cats as Reported by their Owners. Animals, 10(2), 333.

The Airplane Seat of the Future Already Exists, It Cleans Itself and its Protected by Copptech!
Germs and microbes that lurk on airplane seats are a major source of infectious diseases. Most of these germs remain in various places on airplanes, despite the high altitude, temperature changes, air pressure and cleanliness of airline equipment. These germs survive in spite of even cleaning with uv lights and other commonly used cleaners. They live everywhere on an airplane, from the blankets you wrap yourself in, the front seat pocker, seats, tables, seat belts, carpets, windows and toilets.
Studies consistently show that almost everything inside an aircraft cabin is infested with bacteria and viruses. In this study on Transmission of infectious diseases during commercial air travel, they explain that: “The 2002 outbreak of severe acute respiratory syndrome demonstrated how air travel can play an important role in the rapid spread of new emerging infections and may even initiate pandemics. In addition to the flight crew, public health officials and health professionals have an important role in the management of airline-borne infectious diseases and should be familiar with the guidelines provided by local and international authorities” (Mangili, 2005, p. 989).
Communicable diseases can be transmitted rapidly through an aircraft. 2.5 square centimetres of a seatbelt buckle can harbour 1,100 viable bacteria and fungal cells, according to a January report that analysed samples taken from a cabin. A 2014 study by Auburn University in Alabama found that MRSA – a superbug resistant to many antibiotic treatments – can live for a week in the fabric of a seat pocket harboured in a small saliva stain. (Vaglenov, 2014).
The quest for germ-free travel has become commonplace among people, as we all seek to protect ourselves from diseases and germs. The return to safe and secure travel is a priority. Copptech, committed to permanently protecting people, has developed the Copptech Microparticle, which permanently eliminates <99.9% viruses, bacteria and fungi in all types of materials in the interiors of airplanes, cars, buses and other means of transport, from the infrastructure to the upholstery.
Copptech is aware that the design of commercial aircraft has hardly changed in decades, and seats have become the focus of comfort. We firmlu believe that innovation should be promoted not only for comfort, but also to achieve protection and a microbe free experience.
The seats of tomorrow’s airplanes will be protected by Copptech. In addition to self-disinfecting, these seats will also eliminate mites and fleas that passengers might bring on board. A safe and eco-friendly technology that protect both passengers and crew members, permanently – 24/7. Safe travel is possible, innovating to protect people should be a priority.
Learn more about Copptech’s solutions for the Airspace and Transport industry on https://www.copptech.com/cstaging/transport/
(1) Mangili, A., 2005. Transmission of infectious diseases during commercial air travel. Lancet (London, England), 365(9463), 989-996.
(2) Vaglenov, K., 2014. Survival and transmission of selected pathogens on airplane cabin surfaces and selection of phages specific for Campylobacter jejuni (Doctoral dissertation).

Copptech Protected Non Woven Products – Protecting the Healthcare Industry
Copptech technology incorporates antimicrobial formulations into woven and non-woven textiles, polymers, resins and rubbers, turning them into biocidal products, i.e. they neutralise and prevent the action of any harmful microorganism, such as viruses, bacteria and fungi, with an effectiveness of more than 99.9%. In particular, the development of non-woven fabrics has been beneficial in preventing the proliferation of hospital-acquired infections, as this line includes raw materials used in masks, medical gowns, pillowcases, caps and gurney covers, which are widely used in clinics and hospitals. Moreover, this is the same material used in wound dressings, pads and diapers.
“When the microorganism causing an infection comes into contact with a Copptech non-woven, it short-circuits its cell membrane, creating perforations. This allows the copper ions to enter, stopping the pathogen’s vital functions. Copptech technology helps to create an environment free of potentially pathogenic microorganisms around the skin, and if used as an adjunct in wound treatment, it will also contribute to the healing process,” explains Dr Luis Améstica.
People protection can be promoted through the use of technology and innovation. At Copptech, we firmly believe that health and wellbeing are possible and within our reach. The use of Copptech technology in the area of health would be a concrete and effective way to work towards decreasing the spread of pathogenic microorganisms. E-mail us at info@copptech.com/cstaging and we will tell you more about our partners who are already leading the way in the use of technology to protect through non-woven materials.

Certified Projects and Products
We are committed to always achieve the highest level of antimicrobial protection to deliver safety. This is why we certify the efficacy of our products with leading entities, recognised third party laboratories and Universities with science and innovation trayectories, such as the University of Chile and the University of Southampton in the UK.
Copper is the only metal certified by the USA Environmental Protection Agency (EPA) for its antimicrobial properties, and because it does not pollute the environment. And our own Copptech technology already has four EPA registrations, allowing it to be commercialized and guaranteeing its performance.
The efficacy of antimicrobial copper is supported by multiple research studies, one of which was conducted by the US Department of Defense – presented in 2011 in Geneva at the WHO Conference on Infection Prevention. This proved its ability to reduce the risk of infection by more than 40% (Schmidt, 2011).
Copptech has multiple formulations, using different antimicrobial ingredients. We have certifications for all products on the market with our logo. Choosing the Copptech logo is choosing protection, health and wellbeing – all scientifically backed by the highest international standards.
References:
Schmidt, MG. (2011). Copper Touch Surface Initiative Microbiology and Immunology, Medical University of South Carolina, Charleston, USA BMC Proceedings 2011, 5(Suppl 6):O53.